NCT02837159

Brief Summary

The purpose of this randomized study is to assess the efficacy of a mobile application for the promotion of healthy lifestyle habits (diet and exercise) in colorectal cancer survivors (CCR).

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Oct 2016

Typical duration for not_applicable colorectal-cancer

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 14, 2016

Completed
5 days until next milestone

First Posted

Study publicly available on registry

July 19, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

October 1, 2016

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2019

Completed
Last Updated

May 31, 2022

Status Verified

May 1, 2022

Enrollment Period

1.4 years

First QC Date

July 14, 2016

Last Update Submit

May 25, 2022

Conditions

Keywords

colorectal cancerHealth Life Style HabitsHealth

Outcome Measures

Primary Outcomes (1)

  • Body Mass Index

    in kg/m2, will be assessed by conducting Dual-energy X-ray absorptiometry (DXA, discovery densitometer from HOLOGIC, QDR 4500W)

    Participants will be followed over 12 months

Secondary Outcomes (8)

  • Fat mass

    Patients will be followed over 12 months

  • Wait circunferemce

    Patients will be followed over 12 months

  • Hip circunferemce

    Patients will be followed over 12 months

  • Expenditure energy

    Patients will be followed over 12 months

  • Eating habits

    Patients will be followed over 12 months

  • +3 more secondary outcomes

Study Arms (2)

mHealth application

EXPERIMENTAL

The assessment of the end points will be made at three moments: at baseline, at 8 weeks (at the end of the program) and at 12 months of follow-up. The intervention will consist in: 1)Feedback daily or weekly of physical exercise and diet through the application (notice) according to the records of diet and exercise and following recommendations of International Organizations 2) Participation in three sessions of seminars (1 hour each every 15 days) on habits of life healthy and cancer and the self-regulation through measurements performed by the application 3) Calls weekly to the patients of way individual to comment possible errors or doubts about the application, of 10 min of duration (8 calls).

Other: mHealth application

Usual care

NO INTERVENTION

Usual care

Interventions

Dietary and physical activity recommendations trough a mobile application

mHealth application

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Have a diagnosed of colorectal cancer (estadio I-IIIa)
  • Have finished the primary medical treatment.
  • Have a body mass index \> 25
  • Have a level of physical activity \< 3 METS
  • Have access to a Smartphone

You may not qualify if:

  • Physical effort Contraindication from their oncologist
  • Anemia
  • Presence of pathologies that make more difficult the practice of physical activity such as osteoarthritis.
  • Inability to read
  • Severe depression, physical deficits or cognitive
  • Participation in any program or intervention for weight control

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Universidad de Granada

Granada, 18016, Spain

Location

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • IRENE CANTARERO VILLANUEVA, PhD

    Universidad de Granada

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Dra

Study Record Dates

First Submitted

July 14, 2016

First Posted

July 19, 2016

Study Start

October 1, 2016

Primary Completion

March 1, 2018

Study Completion

September 1, 2019

Last Updated

May 31, 2022

Record last verified: 2022-05

Locations